Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	528.79	718.02	114.19
Graham Fair Price	1007.71	5862.03	529.20
PEG	-99.99	< 0.005	0.76
Price/Book	-2.81	0.51	0.52
Price/Cash Flow	3359.86	-143.20	4.14
Prices/Earnings	-99.24	0.55	-71.92
Price/Sales	-3.78	1.04	1.08
Price/FCF	3359.86	-143.20	4.14
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-37.16	0.04	0.06
Operating Margin	-62.49	< 0.005	0.02
ROA	3280.47	0.03	< 0.005
ROE	< 0.005	0.23	12634.19
ROIC	< 0.005	< 0.005	-93.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	3.88	-0.16	2378.48
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.90	-0.63	-78.31
EPS QOQ	0.95	125.88	13190.94
FCF QOQ	1.92	-1.03	-46.46
Revenue QOQ	0.10	< 0.005	-91.53
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	74.46	366.87	392.71
Days Sales Outstanding (DSO)	42.70	372.52	772.43
Inventory Turnover	1.21	0.25	-79.70
Debt/Capitalization	0.48	0.82	71.57
Quick Ratio	0.39	0.56	42.77
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2611.83	2563.81	-1.84
Cash	210.25	947.88	350.84
Capex	-7.54	-4.15	44.98
Free Cash Flow	331.25	-9.13	-97.24
Revenue	1265.69	1255.01	-0.84
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.88	1.04	18.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	70.69	640.98	806.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating